<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02249780</url>
  </required_header>
  <id_info>
    <org_study_id>14-160</org_study_id>
    <nct_id>NCT02249780</nct_id>
  </id_info>
  <brief_title>Assessing Parathyroid Glands Vascularisation by ICG Fluoroscopy</brief_title>
  <official_title>The Use of Indocyanine Green Fluorescence to Assses the Vascularisation of the Parathyroid Glands During Thyroid Surgery</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Hospital, Geneva</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Geneva University, School of medicine</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>University Hospital, Geneva</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Evaluate parathyroid gland perfusion during total thyroidectomy or thyroid totalisation
      surgery. Create an objective basis for the decision whether or not to transplant the
      parathyroid glands. Avoide postoperative serum calcium and parathyroid hormone dosages, and
      thus abstention of systematic supplementation with calcium and vitamin D in case of good
      perfusion.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Parathyroid intraoperative indocyanine green (ICG) angiography is a new concept. To simplify
      the procedure the investigators have classified images into three categories: ICG 2: good
      blood supply (the gland has a white color); ICG 1: traumatic gland (the gland has a grayish
      color) and ICG 0: the gland is not vascularized (she has a black color). The investigators
      have applied the same criteria for visual values.

      The investigators will randomize 138 patients with good ICG test values (at least one gland
      that is visually ≥1 and ICG 2): 69 will be subject to the usual postoperative care in the
      investigators service: 24 hours monitoring with dosage of calcium and PTH in the morning on
      postoperative day 1 and routine supplementation with Calcimagon D3 Forte (1g Calcium and 800
      IU of 25-OH-vitamin D) BD by mouth until postoperative follow-up appointment, which takes
      place between day 10 and 15. Depending on the results of blood tests patients will also be
      given Rocaltrol substitution (1, 25-OH-Vitamin D) 0.5mcg BD. The remaining patients will be
      monitored 24 hours in hospital looking for clinical signs and symptoms of hypocalcemia but
      without any blood dosage or systematic supplementation. If signs and / or symptoms of
      hypocalcemia develop (tingling, muscle spasms, Chvostek sign), a blood test will be performed
      and patients will be substituted by the usual protocol. All patients will be reviewed at 10 -
      15 days of the intervention with the relevant balance sheet.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>September 2014</start_date>
  <completion_date type="Actual">February 2016</completion_date>
  <primary_completion_date type="Actual">February 2016</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Postoperative parathyroid function</measure>
    <time_frame>10 days after surgery</time_frame>
    <description>All patients will be reviewed at 10-15 days after surgery and blood tests will be done. Investigators will check the number of patients with serum calcium and parathyroid hormone in normal ranges at ten days after surgery in both arms of the study. Low parathyroid function will be diagnosed when corrected calcium &lt; 2mmol/l, and PTH &lt; 1.1 pmol/l.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Calcium and parathormone dosage after surgery</measure>
    <time_frame>10 days after surgery</time_frame>
    <description>Number of patients with good calcium and parathormone values at 10 days after surgery without calcium and vitamin D supplementation in the selected group.</description>
  </secondary_outcome>
  <other_outcome>
    <measure>Economic impact</measure>
    <time_frame>From surgery day to 10 days after surgery</time_frame>
    <description>Compare the costs of both procedures: standard procedure and new treatment and then evaluate the economic impact of this preventig mesure, and the possibility to undergo ambulatory surgery</description>
  </other_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">146</enrollment>
  <condition>Parathyroid Function Low Adverse Event</condition>
  <arm_group>
    <arm_group_label>New treatment</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>In patients with at least one well perfused parathyroid gland on ICG parathyroid angiography, no postoperative parathyroid dosage and supplementation will be done. Calcium and parathormone dosage will be done 10 days after surgery.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Standart treatment</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>In those patients in whom at least on of the four parathyroid glands is well perused, postoperative parathyroid function test and parathyroid supplementation will be done. Calcium and parathormone dosage will be done at 24 hours and 10 days after surgery. Prophylactic supplementation of calcium and Vitamin D will be given.</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Postoperative parathyroid function test</intervention_name>
    <description>Calcium and parathormone dosage at 24 hours and ten day after surgery</description>
    <arm_group_label>Standart treatment</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>No postoperative parathyroid dosage and supplementation</intervention_name>
    <description>The patients will be clinically followed for 24 hours after surgery and caclium and parathormone dosage will be done at ten days after surgery. No supplementation will be given.</description>
    <arm_group_label>New treatment</arm_group_label>
    <other_name>Parathiroid function testing</other_name>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>ICG parathyroid angiography</intervention_name>
    <description>Injection of 3,5 mL of indocyanine green intravenously and perform angiography of parathyroid glands after thyroid removal.</description>
    <arm_group_label>New treatment</arm_group_label>
    <arm_group_label>Standart treatment</arm_group_label>
    <other_name>Indoyanine green angiography</other_name>
    <other_name>Indoyanine green fluoroscopy</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Parathyroid supplementation</intervention_name>
    <description>Supplementration with Calcimagon D3 Forte (1gr Calcium and 800 IU of 25-OH-vitamin D) from surgery day to up to 10 days afeter surgery.</description>
    <arm_group_label>Standart treatment</arm_group_label>
    <other_name>Hypocalcemia post thyroidectomy treatment</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Adult patients undergoing total thyroidectomy or a totalisation thyroid procedure.

          -  Patients capable of understanding and able to understand the study.

          -  Values visually 2 and ICG 2

        Exclusion Criteria:

          -  Parathyroid disease or prior parathyroidectomy

          -  Lack of informed consent

          -  Altered mental status of the patient.

          -  ICG values &lt;2.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Frédéric Triponez, Professor</last_name>
    <role>Study Director</role>
    <affiliation>University Hospitals Geneva</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Wolfram Karenovics, SPR</last_name>
    <role>Principal Investigator</role>
    <affiliation>University Hospitals Geneva</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Frédéric Ris, Consultant</last_name>
    <role>Principal Investigator</role>
    <affiliation>University Hospitals Geneva</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Valentina Belfontali, Resident</last_name>
    <role>Principal Investigator</role>
    <affiliation>University Hospitals Geneva</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Jordi Vidal Fortuny, SPR</last_name>
    <role>Study Chair</role>
    <affiliation>University Hospitals Geneva</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>University Hospitals Geneva</name>
      <address>
        <city>Geneva</city>
        <zip>1205</zip>
        <country>Switzerland</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Switzerland</country>
  </location_countries>
  <verification_date>September 2014</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>September 15, 2014</study_first_submitted>
  <study_first_submitted_qc>September 22, 2014</study_first_submitted_qc>
  <study_first_posted type="Estimate">September 26, 2014</study_first_posted>
  <last_update_submitted>April 15, 2016</last_update_submitted>
  <last_update_submitted_qc>April 15, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">April 18, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University Hospital, Geneva</investigator_affiliation>
    <investigator_full_name>JORDI VIDAL FORTUNY</investigator_full_name>
    <investigator_title>Chef de clinique</investigator_title>
  </responsible_party>
  <keyword>Parathyroid gland angiography</keyword>
  <keyword>Parathyroid gland indocyanine green angiography</keyword>
  <keyword>Parathyroid gland indocyanine green fluoroscopy</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Neovascularization, Pathologic</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Calcium, Dietary</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

